Diagnosis and pharmacotherapy of conduct disorder

Abstract

Lavin Michael R. and Arthur Rifkin: Diagnosis and Pharmacotherapy of Conduct Disorders. Prog. Neuro- Psychopharmacol. & Biol. Psychiat. 1993, 17(6): 875–885. 1. 1. There are few double-blind, placebo-controlled studies of the drug treatment of conduct disorders in children and adolescents. 2. 2. The diagnosis of conduct disorders involves a persistent pattern of behavior in which the basic rights of others and standards of society are violated. 3. 3. There is frequent comorbidity associated with conduct disorders including attention-deficit hyperactivity disorder, oppositional defiant disorder, mood disorders and substance abuse. 4. 4. Childhood Conduct disorder is associated with a significant risk for adult psychopathology. 5. 5. A variety of treatment approaches may be employed to combat conduct disorders. 6. 6. The use of neuroleptics, lithium carbonate, stimulants and other agents is reviewed.